046 iPreg Inc-200x200.png

iPreg Inc.

好孕行公司創立於2018年7月,由東吳大學鍾成晏教授與一群豐富開發經驗之專業人士所建立的團隊,致力於輔助生殖產品之研究開發,透過獨特專利技術,以高效率、低成本,提供客戶確實、有效的精子快篩晶片,相較傳統方式能更高效地篩選出優質精子,提升試管嬰兒成功率。


iPreg Incorporation is a manufacturer of biomedical device focusing on reproductive medicine. Established in 2018, we researched the human sperm swimming mode and found that there is a discernible difference in the swimming ability between healthy and abnormal sperm. Therefore, "iPreg sperm sorting chip" was invented." The global population of infertility is about 15%. "iPreg sperm sorting chip" can increase the healthy sperm ratio to 95% in 10 minutes, Giving advantages of safety, highly recovery and efficiency, which can facilitate IVF in the key step of sperm screening, further improve the success rate of assisted reproduction.

 

公司沿革

好孕行公司著重開發高效率且人性化的體外檢測晶片,以台灣為研發基地,佈局美國、大陸及台灣的市場,進而成為全球體外檢測試劑之標竿企業。產品主要透過醫院及醫療機構進行產品銷售,為了進一步拓展全球市場版圖,我們致力於輔助生殖服務產業多元化的開發,盡力為患者提供高品質產品,持續進行科學方面研究,改善輔助生育治療的成效。

 
 
123600966_150055676864356_76029814196348

鍾成晏 博士  Chen-Yen Chung

創辦人      Founder and CEO

・東吳大學微生物系助理教授・英國愛丁堡大學免疫系博士
・博醫股份有限公司創辦人・中央研究院生物醫學研究所
PhD in Immunology from the University of Edinburgh, UK. He studied autoimmune diseases at the Institute of Biomedicine, Academia Sinica from 2009 to 2015, and served as an adjunct assistant professor in the Department of Microbiology at Soochow University. In 2013, Dr. Chung founded Medoc Incorporation specialized in the research and development, manufacturing and sales of health and beauty products. Dr. Chung founded iPreg Incorporation and the core technology is to implement flow cytometry technology with micro-channel chips.